Medication

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., May 27, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…

Some Canadians will be able to buy brand-name GLP-1 drug Ozempic at a reduced price, Danish drugmaker Novo…

First medicine for pre-symptomatic type 1 diabetes Media Release by Sanofi ANZ/Posted Wednesday,27 may,2026 Key facts: – First…

A UK tribunal suspended Chirag Patel for eight months after finding he had a sexual relationship with a…

Nathan Coleman still remembers the exact moment he vowed to lose weight — a “turning point” that led…

“We know of one person who’s bought medication online from one of these websites but hasn’t received any…

“In a way, my mother speaks for all the mothers and for the children,” Sharon Clarken says. “The…

Eliquis (apixaban) is one of the most commercially consequential loss-of-exclusivity (LOE) events in recent pharmaceutical history, with patent…

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…

By Adam J. Fein, Ph.D.Summer unofficially kicked off last weekend. So fire up the grill and enjoy these…

While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…

The South African Health Products Regulatory Authority (SAHPRA), in a decisive move to protect public health, has intensified…

BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting